Body Mass Index and Repeat Revascularization After Percutaneous Coronary Intervention: A Meta-analysis

Canadian Journal of Cardiology

Volumn 31, Issue 6, 2015, Pages 800-808

  Wang, Zhi Jian ^a   Gao, Fei ^a   Cheng, Wan Jun ^a   Yang, Qing ^a   Zhou, Yu Jie ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BARE METAL STENT; BODY MASS; BODY WEIGHT; COCHRANE LIBRARY; DATA BASE; DISEASE SEVERITY; DRUG ELUTING STENT; EMBASE; HEART MUSCLE REVASCULARIZATION; HUMAN; MEDLINE; META ANALYSIS; MORTALITY; OBESITY; PERCUTANEOUS CORONARY INTERVENTION; QUALITY CONTROL; REVIEW; RISK ASSESSMENT; SYSTEMATIC REVIEW; UNDERWEIGHT; CORONARY RESTENOSIS; CORONARY STENOSIS; FEMALE; INCIDENCE; MALE; PROCEDURES; PROGNOSIS; RADIOGRAPHY; RETREATMENT; STENT; SURVIVAL; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

ANGIOPLASTY, BALLOON, CORONARY; BODY MASS INDEX; CORONARY RESTENOSIS; CORONARY STENOSIS; FEMALE; HUMANS; INCIDENCE; MALE; OBESITY; PERCUTANEOUS CORONARY INTERVENTION; PROGNOSIS; RETREATMENT; RISK ASSESSMENT; STENTS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84929841687     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cjca.2015.01.031     Document Type: Review

References (32)

1. Berrington de Gonzalez A., Hartge P., Cerhan J.R., et al. Body mass index and mortality among 1.46 million white adults. NEngl J Med 2010, 363:2211-2219. [erratum in N Engl J Med 2011;365:869].
2. Chen Z., Yang G., Offer A., et al. Body mass index and mortality in China: a 15-year prospective study of 220 000 men. Int J Epidemiol 2012, 41:472-481.
3. Global database on body mass index. Body mass index classification of WHO. Available at: . Accessed April 20, 2013. http://apps.who.int/bmi/index.jsp?introPage=intro_3.html.
4. Romero-Corral A., Montori V.M., Somers V.K., et al. Association of body weight with total mortality and with cardiovascular events in coronary artery disease: a systematic review of cohort studies. Lancet 2006, 368:666-678.
5. Gruberg L., Weissman N.J., Waksman R., et al. The impact of obesity on the short-term and long-term outcomes after percutaneous coronary intervention: the obesity paradox?. JAm Coll Cardiol 2002, 39:578-584.
6. Lancefield T., Clark D.J., Andrianopoulos N., et al. Is there an obesity paradox after percutaneous coronary intervention in the contemporary era? An analysis from a multicenter Australian registry. JACC Cardiovasc Interv 2010, 3:660-668.
7. Angerås O., Albertsson P., Karason K., et al. Evidence for obesity paradox in patients with acute coronary syndromes: a report from the Swedish Coronary Angiography and Angioplasty Registry. Eur Heart J 2013, 34:345-353.
8. Sharma A., Vallakati A., Einstein A.J., et al. Relationship of body mass index with total mortality, cardiovascular mortality, and myocardial infarction after coronary revascularization: evidence from a meta-analysis. Mayo Clin Proc 2014, 89:1080-1100.
9. Stroup D.F., Berlin J.A., Morton S.C., et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000, 283:2008-2012.
10. Wells GA, Shea B, O'Connell D, etal. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Available at: . Accessed April 20, 2013. http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp.
11. Higgins J.P., Thompson S.G., Deeks J.J., Altman D.G. Measuring inconsistency in meta-analyses. BMJ 2003, 327:557-560.
12. Begg C.B., Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994, 50:1088-1101.
13. Khattab A.A., Daemen J., Richardt G., et al. Impact of body mass index on the one-year clinical outcome of patients undergoing multivessel revascularization with sirolimus-eluting stents (from the Arterial Revascularization Therapies Study Part II). Am J Cardiol 2008, 101:1550-1559.
14. Sarno G., Garg S., Onuma Y., et al. The impact of body mass index on the one year outcomes of patients treated by percutaneous coronary intervention with biolimus- and sirolimus-eluting stents (from the LEADERS Trial). Am J Cardiol 2010, 105:475-479.
15. Sarno G., Rber L., Onuma Y., et al. Impact of body mass index on the five-year outcome of patients having percutaneous coronary interventions with drug-eluting stents. Am J Cardiol 2011, 108:195-201.
16. Akin I., Tölg R., Hochadel M., et al. No evidence of "obesity paradox" after treatment with drug-eluting stents in a routine clinical practice: results from the prospective Multicenter German DES.DE (German Drug-Eluting Stent) registry. JACC Cardiovasc Interv 2012, 5:162-169.
17. Wang Z.J., Zhou Y.J., Zhao Y.X., et al. Effect of obesity on repeat revascularization in patients undergoing percutaneous coronary intervention with drug-eluting stents. Obesity (Silver Spring) 2012, 20:141-146.
18. Poston W.S., Haddock C.K., Conard M., Spertus J.A. Impact of obesity on disease-specific health status after percutaneous coronary intervention in coronary disease patients. Int J Obes Relat Metab Disord 2004, 28:1011-1017.
19. Gruberg L., Mercado N., Milo S., et al. Impact of body mass index on the outcome of patients with multivessel disease randomized to either coronary artery bypass grafting or stenting in the ARTS trial: the obesity paradox II?. Am J Cardiol 2005, 95:439-444.
20. Rana J.S., Mittleman M.A., Ho K.K., Cutlip D.E. Obesity and clinical restenosis after coronary stent placement. Am Heart J 2005, 150:821-826.
21. Nikolsky E., Stone G.W., Grines C.L., et al. Impact of body mass index on outcomes after primary angioplasty in acute myocardial infarction. Am Heart J 2006, 151:168-175.
22. Kaneko H., Yajima J., Oikawa Y., et al. Obesity paradox in Japanese patients after percutaneous coronary intervention: an observation cohort study. JCardiol 2013, 62:18-24.
23. Nikolsky E., Kosinski E., Mishkel G.J., et al. Impact of obesity on revascularization and restenosis rates after bare-metal and drug-eluting stent implantation (from the TAXUS-IV trial). Am J Cardiol 2005, 95:709-715.
24. Uretsky S., Messerli F.H., Bangalore S., et al. Obesity paradox in patients with hypertension and coronary artery disease. Am J Med 2007, 120:863-870.
25. Tobias D., Pan A., Hu F.B. BMI and mortality among adults with incident type 2 diabetes. NEngl J Med 2014, 370:1363-1364.
26. Oreopoulos A., McAlister F.A., Kalantar-Zadeh K., et al. The relationship between body mass index, treatment, and mortality in patients with established coronary artery disease: a report from APPROACH. Eur Heart J 2009, 30:2584-2592.
27. Rubinshtein R., Halon D.A., Jaffe R., Shahla J., Lewis B.S. Relation between obesity and severity of coronary artery disease in patients undergoing coronary angiography. Am J Cardiol 2006, 97:1277-1280.
28. Diercks D.B., Roe M.T., Mulgund J., et al. The obesity paradox in non-ST-segment elevation acute coronary syndromes: results from the Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the American College of Cardiology/American Heart Association Guidelines Quality Improvement Initiative. Am Heart J 2006, 152:140-148.
29. De Schutter A., Lavie C.J., Arce K., Menendez S.G., Milani R.V. Correlation and discrepancies between obesity by body mass index and body fat in patients with coronary heart disease. JCardiopulm Rehabil Prev 2013, 33:77-83.
30. Romero-Corral A., Somers V.K., Sierra-Johnson J., et al. Diagnostic performance of body mass index to detect obesity in patients with coronary artery disease. Eur Heart J 2007, 28:2087-2093.
31. Walter D.H., Schächinger V., Elsner M., et al. Effect of statin therapy on restenosis after coronary stent implantation. Am J Cardiol 2000, 8:962-968.
32. Arandomized, double-blind, multicenter comparison study of triple antiplatelet therapy with dual antiplatelet therapy to reduce restenosis after drug-eluting stent implantation in long coronary lesions: results from the DECLARE-LONG II trial. JAm Coll Cardiol 2011, 57:1264-1270. DECLARE-LONG II Study Investigators.